Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: A non-inferiority controlled trial

European Journal of Nutrition

Volumn 51, Issue 2, 2012, Pages 221-229

  Zaim, Mohammed ^a   Piselli, Leonardo ^b   Fioravanti, Pino ^c   Kanony Truc, Claire ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b Hippocrates Research Srl ^*  (Italy)

^c Hippocrates Research Srl   (Italy)

Author keywords

Ferrous sulphate; Gastrointestinal tolerance; Iron deficiency anaemia; Non inferiority

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; V 0355;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; GASTROENTERITIS; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR VOLUME; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TREATMENT OUTCOME; VOMITING;

EID: 84860660487     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-011-0210-7     Document Type: Article

References (21)

1. Iolascon A, De Falco L, Beaumont C (2009) Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica 94(3):395-408. doi:10.3324/haematol.13619
2. World Health Organization (2004) Assessing the iron status of population. Report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level. WHO, Geneva
3. Beutler E, Waalen J (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107(5):1747-1750. doi:10.1182/blood-2005-07-3046 (Pubitemid 43289347)
4. Cook JD (2005) Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 18(2):319-332. doi: 10.1016/j.beha.2004.08.022 (Pubitemid 40298373)
5. World Health Organization (2001) Iron deficiency anaemia: assessment, prevention and control. WHO, Geneva
6. Munoz M, Villar I, Garcia-Erce JA (2009) An update on iron physiology. World J Gastroenterol 15(37):4617-4626
7. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352(10):1011-1023. doi:10.1056/NEJMra041809 (Pubitemid 40349504)
8. Stoltzfus RJ, Dreyfuss M, International Nutritional Anemia Consultative Group (1998) Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Ilsi Press, Washington
9. Allen LH (2002) Iron supplements: scientific issues concerning efficacy and implications for research and programs. J Nutr 132(4 Suppl):813S-819S (Pubitemid 34275088)
10. Lozoff B (2007) Iron deficiency and child development. Food Nutr Bull 28(4 Suppl):S560-S571 (Pubitemid 351149506)
11. Haas JD, Brownlie Tt (2001) Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 131(2 S-2):676S-688S; discussion 688S-690S
12. Steiner LA, Gallagher PG (2007) Erythrocyte disorders in the perinatal period. Semin Perinatol 31(4):254-261. doi: 10.1053/j.semperi.2007.05.003 (Pubitemid 47348098)
13. Hillman R (2006) Iron and iron salts. In: Hill M (ed) Drugs acting on the blood and the blood forming organs. McGraw Hill, pp 1-13
14. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ (2006) Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 295(10):1152-1160. doi:10.1001/jama.295.10.1152 (Pubitemid 43352345)
15. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51(11):1171-1178 (Pubitemid 28527173)
16. Beguin Y (2003) Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 329(1-2):9-22 (Pubitemid 36183479)
17. Kohgo Y, Niitsu Y, Kondo H, Kato J, Tsushima N, Sasaki K, Hirayama M, Numata T, Nishisato T, Urushizaki I (1987) Serum transferrin receptor as a new index of erythropoiesis. Blood 70(6):1955-1958 (Pubitemid 18055649)
18. British Columbia Advisory Committee (2010) Iron deficiency-Investigation and management. http://www.bcguidelines.ca/gpac/pdf/iron-deficiency.pdf
19. Idoate Gastearena MA, Gil AG, Azqueta A, Coronel MP, Gimeno M (2003) A comparative study on the gastroduodenal tolerance of different antianaemic preparations. Hum Exp Toxicol 22(3):137-141 (Pubitemid 36511870)
20. Grabe DW (2007) Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease. Am J Health Syst Pharm 64(13 Suppl 8):S8-S14; quiz S23-15, doi:10.2146/ajhp070182 (Pubitemid 47025529)
21. Higgins P D R, Rockey DC (2003) Iron-deficiency Anemia. Tech Gastrointest Endosc 5(3):134-141. doi:10.1053/j.tgie.2003. 08.002 (Pubitemid 38088652)